Andrew is the Founder and CEO of Renthera. Andrew also serves as the Chief Investment Officer at Gödel Escher which focuses on pharmaceutical and biotechnology investments. Prior to Renthera, Andrew managed the Global Macro Portfolio at Blue Creek Asset Management in Hong Kong in addition to leading the Quantitative and Derivatives Strategy team. Andrew studied Molecular Biology at Georgetown University and postgraduate Mathematical and Computational Finance at Oriel College at Oxford University.
Hotaru leads the company’s therapeutics group which is responsible for preclinical drug discovery, translational research, and early clinical development, Hotaru has more than 10 years of experience in academia, pharmaceutical R&D, partnerships, and licensing. Hotaru was previously Co-Director of Clinical Pharmacology and Pharmacometrics at Otsuka Holdings for 4.5 years before coming to Renthera. In the past, Hotaru has been a development team leader working on first-in-human studies through late-stage label studies. Hotaru received his Ph.D. from the University of Chicago in molecular biosciences. After post-doctoral training at Imperial and the Ludwig Institute for Cancer Research (UCL).
Suzie taught molecular sciences at Fudan University and was a senior computational geneticist at Xinghua Biomedical before Renthera. She also served as Assistant Director of the Tumor Biotherapy Laboratory at ZhongShan Hospital, Fudan University, for six years. She earned her doctorate of Philosophy in Cell Physiology from Osaka University in Japan.
Prior to Joining Renthera, Cedric acted as principal technologist at Gödel Escher, an asset management firm based in New York City. Cedric led architecture technology in the machine learning capability of Gödel’s proprietary software. Cedric studied Chemistry at Oxford University.
R.C. Chai , Sai, has a Masters of Science from the University of Texas at Austin in Electrical and Computer Engineering. Before joining Renthera, Sai was an ASICS engineer at NVDIIA and and senior design engineer at Qualcomm.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.